Last $14.54 USD
Change Today +0.64 / 4.60%
Volume 582.3K
CEMP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

cempra inc (CEMP) Snapshot

Open
$13.90
Previous Close
$13.90
Day High
$14.67
Day Low
$13.90
52 Week High
01/22/14 - $15.39
52 Week Low
04/15/14 - $8.10
Market Cap
521.1M
Average Volume 10 Days
361.9K
EPS TTM
$-1.85
Shares Outstanding
35.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CEMPRA INC (CEMP)

cempra inc (CEMP) Related Businessweek News

No Related Businessweek News Found

cempra inc (CEMP) Details

Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases in North America. Its two lead product candidates include Solithromycin (CEM-101), which is in a Phase III clinical trial for community-acquired bacterial pneumonia (CABP); and TAKSTA (CEM-102) that is in a Phase II clinical trial for prosthetic joint infections. The company also focuses on using its series of proprietary lead compounds from its novel macrolide library for uses, such as the treatment of chronic inflammatory diseases, endocrine diseases, and gastric motility disorders. It has collaborative research and development and license agreement with Optimer Pharmaceuticals, Inc. The company was formerly known as Cempra Holdings, LLC and changed its name to Cempra, Inc. in February 2012. Cempra, Inc. was founded in 2005 and is headquartered in Chapel Hill, North Carolina.

38 Employees
Last Reported Date: 02/28/14
Founded in 2005

cempra inc (CEMP) Top Compensated Officers

Founder, Chief Executive Officer, President a...
Total Annual Compensation: $447.2K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $292.6K
Compensation as of Fiscal Year 2013.

cempra inc (CEMP) Key Developments

Cempra, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 12:20 PM

Cempra, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 12:20 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom. Speakers: Prabhavathi B. Fernandes, Founder, Chief Executive Officer, President and Director.

Cempra, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 01:50 PM

Cempra, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 01:50 PM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Prabhavathi B. Fernandes, Founder, Chief Executive Officer, President and Director.

Cempra, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Cempra, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $7,766,000 compared to $1,172,000 a year ago. The higher revenue was due to the recognition of $4.3 million of revenue related to the Toyama milestone payment received in the quarter and higher revenue related to increased activity under the BARDA relationship this quarter. Loss from operations was $10,740,000 compared to $12,914,000 a year ago. Net loss attributable to common shareholders was $11,356,000 or $0.34 per basic and diluted share compared to $13,647,000 or $0.41 per basic and diluted share a year ago. For the nine months, the company reported revenues of $12,746,000 compared to $5,740,000 a year ago. Loss from operations was $43,137,000 compared to $26,773,000 a year ago. Net loss attributable to common shareholders was $44,754,000 or $1.34 per basic and diluted share compared to $28,205,000 or $1.00 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMP:US $14.54 USD +0.64

CEMP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CEMP.
View Industry Companies
 

Industry Analysis

CEMP

Industry Average

Valuation CEMP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 33.0x
Price/Book 12.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEMPRA INC, please visit www.cempra.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.